Skip to content

A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension

A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02895386
Acronym
CONTROL HTN-2
Enrollment
30
Registered
2016-09-09
Start date
2017-03-22
Completion date
2019-05-01
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure, Hypertension

Keywords

Hypertension, High Blood Pressure, Systolic Blood Pressure, Uncontrolled Hypertension, Essential Hypertension, Resistant Hypertension, Vascular Disease

Brief summary

To evaluate the safety and effectiveness of the ROX Coupler used to create an arteriovenous anastomosis in the iliac region (between the iliac artery and vein) in subjects with hypertension.

Interventions

ROX Coupler will be used to create an anastomosis in the iliac region (between the iliac artery and vein).

OTHERSham procedure

Sham procedure + continuing current antihypertensive medications.

Sponsors

ROX Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
22 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Mean 24-hour ambulatory blood pressure monitoring (ABPM) SBP ≥ 140 mmHg at screening.

Exclusion criteria

* Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in mean 24-hour Ambulatory Blood Pressure Monitor systolic blood pressureBaseline, 6 monthsChange in mean 24-hour Ambulatory Blood Pressure Monitor systolic blood pressure at six month as compared to Baseline

Secondary

MeasureTime frameDescription
Change in mean office systolic blood pressureBaseline, 6 monthsChange in mean office systolic blood pressure at six months as compared to Baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026